Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dalrada Technology GroupDHTI EV-to-EBITDA is -1.24 as of Jul. 17, 2026. The stock has 8 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Dalrada Technology Group ranks worse than 197238.46% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Dalrada Technology Group's enterprise value is $21.42 Mil.
Dalrada Technology Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-17.32 Mil. Therefore, Dalrada Technology Group's EV-to-EBITDA for today is -1.24.
The historical rank and industry rank for Dalrada Technology Group's EV-to-EBITDA or its related term are showing as below:
DHTI'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -682.81 Med: -1.37 Max: 461.62
Current: -1.24
During the past 13 years, the highest EV-to-EBITDA of Dalrada Technology Group was 461.62. The lowest was -682.81. And the median was -1.37.
DHTI's EV-to-EBITDA is ranked worse than 100% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 11.1
vs DHTI: -1.24
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Dalrada Technology Group (OTCPK:DHTI) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Dalrada Technology Group's PE Ratio (TTM) for today is calculated as:
Dalrada Technology Group's share price for today is $0.0197.
Dalrada Technology Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Dalrada Technology Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dalrada Technology Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dalrada Technology Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dalrada Technology Group's EV-to-EBITDA falls into.
Dalrada Technology Group's current Enterprise Value is $21.42 Mil.
Dalrada Technology Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dalrada Technology Group (DHTI) has a EV-to-EBITDA of -1.24 as of Jul. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dalrada Technology Group. According to the industry distribution chart, Dalrada Technology Group ranks #999999 out of 507 companies in the Healthcare Providers & Services industry.
Is Dalrada Technology Group's EV-to-EBITDA too high?
Dalrada Technology Group's current EV-to-EBITDA is -1.24. Based on the distribution chart, Dalrada Technology Group ranks #999999 out of 507 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Dalrada Technology Group's EV-to-EBITDA compare to PMHS and RDGT?
According to the Healthcare Providers & Services industry distribution chart, Dalrada Technology Group ranks #999999 out of 507 companies for EV-to-EBITDA. This places Dalrada Technology Group in the lower half of its industry. The industry median EV-to-EBITDA is 11.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.10, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Dalrada Technology Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dalrada Technology Group's current EV-to-EBITDA is -1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dalrada Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dalrada Technology Group (DHTI) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.02 — trading 60.6% below its estimated fair value. The current EV-to-EBITDA is -1.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Dalrada Technology Group (DHTI), the current EV-to-EBITDA is -1.24 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dalrada Technology Group Inc is a United States-based company engaged in providing commercial and home heat pumps, building advanced physical deposition solutions for semiconductor manufacturers and clean energy applications, and driving enhanced healthcare initiatives through its subsidiaries like specialty pharmacy. Its business segments include: Climate Technology; Deposition Technology; and Genefic Healthcare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHTI has been successfully added to your 
